2021
DOI: 10.1016/j.ijbiomac.2021.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Recent updates in the polysaccharides-based Nano-biocarriers for drugs delivery and its application in diseases treatment: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(18 citation statements)
references
References 168 publications
0
12
0
Order By: Relevance
“…Alterations to the surface area and/or volume of the NPs will lead to modifications of their properties, such as their mechanical, thermal, optical, and catalytic behaviour, which can be exploited in diverse applications, such as in the biological fields [ 20 , 21 ]. In the last decade, the fabrication of NPs based on polysaccharides [ 22 ], polymers [ 23 , 24 ], and plant-derived bioactive compounds [ 25 ] incorporated with active drugs has proven to be efficient in treating various pathological conditions.…”
Section: Types and Methods Of Synthesis Of Nanoparticlesmentioning
confidence: 99%
“…Alterations to the surface area and/or volume of the NPs will lead to modifications of their properties, such as their mechanical, thermal, optical, and catalytic behaviour, which can be exploited in diverse applications, such as in the biological fields [ 20 , 21 ]. In the last decade, the fabrication of NPs based on polysaccharides [ 22 ], polymers [ 23 , 24 ], and plant-derived bioactive compounds [ 25 ] incorporated with active drugs has proven to be efficient in treating various pathological conditions.…”
Section: Types and Methods Of Synthesis Of Nanoparticlesmentioning
confidence: 99%
“…Natural polysaccharides are biocompatible, biodegradable, and non-toxic, making them great candidates for drug delivery. Among them, chitosan (CS) and cyclodextrin (CDs) are commonly used [ 113 , 114 , 115 ] and have demonstrated excellent efficacy in siRNA-mediated gene silencing. Alternatively, polysaccharides can also be combined with other vectors to reduce toxicity.…”
Section: Sirna Nanocarriersmentioning
confidence: 99%
“…[ 352 , 353 ] Similarly, other proteins have been used as the structural component rather than eliciting any specific effect inherent to that protein. [ 354 , 355 ]…”
Section: Protein Particles In Nanomedicinementioning
confidence: 99%